The interleukin-33 receptor ST2 is important for the development of peripheral airway hyperresponsiveness and inflammation in a house dust mite mouse model of asthma

Clinical and Experimental Allergy

Volumn 46, Issue 3, 2016, Pages 479-490

  Zoltowska, A M ^a   Lei, Y ^a,c   Fuchs, B ^a,b   Rask, C ^d   Adner, M ^b   Nilsson, G P ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c XI'AN JIAOTONG UNIVERSITY   (China)

^d ALK ABELLÓ   (Denmark)

Author keywords

AHR; Asthma; IL 33; ST2

Indexed keywords

ALLERGEN; CHYMASE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 33; INTERLEUKIN 33 RECEPTOR ST2; INTERLEUKIN 5; INTERLEUKIN RECEPTOR; THYMIC STROMAL LYMPHOPOIETIN; UNCLASSIFIED DRUG; AUTACOID; CCL2 PROTEIN, MOUSE; CYTOKINE; IL1RL1 PROTEIN, HUMAN; INTERLEUKIN 1 RECEPTOR LIKE 1 PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CELL ACTIVITY; CELL INFILTRATION; CONTROLLED STUDY; DERMATOPHAGOIDES; FEMALE; GOBLET CELL; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; INFLAMMATORY CELL; LUNG FUNCTION; LUNG HOMOGENATE; MACROPHAGE; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; AIRWAY REMODELING; ANIMAL; DISEASE MODEL; GENE EXPRESSION; GENETICS; IMMUNIZATION; IMMUNOLOGY; KNOCKOUT MOUSE; LUNG; METABOLISM; PATHOLOGY; PYROGLYPHIDAE; SIGNAL TRANSDUCTION;

AIRWAY REMODELING; ALLERGENS; ANIMALS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINE CCL2; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; IMMUNIZATION; IMMUNOGLOBULIN E; INFLAMMATION MEDIATORS; INTERLEUKIN-1 RECEPTOR-LIKE 1 PROTEIN; INTERLEUKIN-33; LUNG; MAST CELLS; MICE; MICE, KNOCKOUT; PYROGLYPHIDAE; SIGNAL TRANSDUCTION;

EID: 84959048130     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12683     Document Type: Article

References (45)

1. Holgate ST. Epithelium dysfunction in asthma. J Allergy Clin Immunol 2007; 120:1233-44.
2. Lambrecht BN, Hammad H. The airway epithelium in asthma. Nat Med 2012; 18:684-92.
3. Schmitz J, Owyang A, Oldham E et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005; 23:479-90.
4. Moffatt MF, Gut IG, Demenais F et al. A large-scale, consortium-based genomewide association study of asthma. N Engl J Med 2010; 363:1211-21.
5. Torgerson DG, Ampleford EJ, Chiu GY et al. Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations. Nat Genet 2011; 43:887-92.
6. Oboki K, Nakae S, Matsumoto K, Saito H. IL-33 and airway inflammation. Allergy Asthma Immunol Res 2011; 3:81-8.
7. Prefontaine D, Nadigel J, Chouiali F et al. Increased IL-33 expression by epithelial cells in bronchial asthma. J Allergy Clin Immunol 2010; 125:752-4.
8. Saglani S, Lui S, Ullmann N et al. IL-33 promotes airway remodeling in pediatric patients with severe steroid-resistant asthma. J Allergy Clin Immunol 2013; 132:676-85.e13.
9. Kondo Y, Yoshimoto T, Yasuda K et al. Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system. Int Immunol 2008; 20:791-800.
10. Kurowska-Stolarska M, Stolarski B, Kewin P et al. IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J Immunol 2009; 183:6469-77.
11. Gregory LG, Lloyd CM. Orchestrating house dust mite-associated allergy in the lung. Trends Immunol 2011; 32:402-11.
12. Asokananthan N, Graham PT, Stewart DJ et al. House dust mite allergens induce proinflammatory cytokines from respiratory epithelial cells: the cysteine protease allergen, Der p 1, activates protease-activated receptor (PAR)-2 and inactivates PAR-1. J Immunol 2002; 169:4572-8.
13. Trompette A, Divanovic S, Visintin A et al. Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein. Nature 2009; 457:585-8.
14. Willart MA, Deswarte K, Pouliot P et al. Interleukin-1alpha controls allergic sensitization to inhaled house dust mite via the epithelial release of GM-CSF and IL-33. J Exp Med 2012; 209:1505-17.
15. van den Berge M, ten Hacken NH, Cohen J, Douma WR, Postma DS. Small airway disease in asthma and COPD: clinical implications. Chest 2011; 139:412-23.
16. Townsend MJ, Fallon PG, Matthews DJ, Jolin HE, McKenzie AN. T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses. J Exp Med 2000; 191:1069-76.
17. Swedin L, Ellis R, Kemi C et al. Comparison of aerosol and intranasal challenge in a mouse model of allergic airway inflammation and hyperresponsiveness. Int Arch Allergy Immunol 2010; 153:249-58.
18. Fuchs B, Sjoberg L. Moller Westerberg C, Ekoff M, Swedin L, Dahlen SE, Adner M, Nilsson GP, Mast cell engraftment of the peripheral lung enhances airway hyperresponsiveness in a mouse asthma model. Am J Physiol Lung Cell Mol Physiol 2012; 303:L1027-36.
19. Irvin CG, Bates JH. Measuring the lung function in the mouse: the challenge of size. Respir Res 2003; 4:4.
20. Bates JH, Lutchen KR. The interface between measurement and modeling of peripheral lung mechanics. Respir Physiol Neurobiol 2005; 148:153-64.
21. Woodhead JS, Weeks I. Magic Lite design and development. J Biolumin Chemilumin 1989; 4:611-4.
22. Swedin L, Ellis R, Neimert-Andersson T et al. Prostaglandin modulation of airway inflammation and hyperresponsiveness in mice sensitized without adjuvant. Prostaglandins Other Lipid Mediat 2010; 92:44-53.
23. Singh B, Shinagawa K, Taube C, Gelfand EW, Pabst R. Strain-specific differences in perivascular inflammation in lungs in two murine models of allergic airway inflammation. Clin Exp Immunol 2005; 141:223-9.
24. Pinelli V, Marchica CL, Ludwig MS. Allergen-induced asthma in C57Bl/6 mice: hyper-responsiveness, inflammation and remodelling. Respir Physiol Neurobiol 2009; 169:36-43.
25. Borges MC, Marchica CL, Narayanan V, Ludwig MS. Allergen challenge during halothane compared to isoflurane anesthesia induces a more potent peripheral lung response. Respir Physiol Neurobiol 2013; 189:144-52.
26. Townsend MJ, Fallon PG, Matthews DJ, Smith P, Jolin HE, McKenzie ANJ. IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. Immunity 2000; 13:573-83.
27. Snelgrove RJ, Gregory LG, Peiro T et al. Alternaria-derived serine protease activity drives IL-33 mediated asthma exacerbations. J Allergy Clin Immunol 2014; 134:583-92.
28. Coyle AJ, Lloyd C, Tian J et al. Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses. J Exp Med 1999; 190:895-902.
29. Barlow JL, Peel S, Fox J et al. IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction. J Allergy Clin Immunol 2013; 132:933-41.
30. Oboki K, Ohno T, Kajiwara N et al. IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc Natl Acad Sci U S A 2010; 107:18581-6.
31. Bates JH, Rincon M, Irvin CG. Animal models of asthma. Am J Physiol Lung Cell Mol Physiol 2009; 297:L401-10.
32. Wagers S, Lundblad LK, Ekman M, Irvin CG, Bates JH. The allergic mouse model of asthma: normal smooth muscle in an abnormal lung? J Appl Physiol (1985) 2004; 96:2019-27.
33. Sjoberg LC, Gregory JA, Dahlen SE, Nilsson GP, Adner M. Interleukin-33 exacerbates allergic bronchoconstriction in the mice via activation of mast cells. Allergy 2015; 70:514-21.
34. Nakanishi W, Yamaguchi S, Matsuda A et al. IL-33, but not IL-25, is crucial for the development of house dust mite antigen-induced allergic rhinitis. PLoS One 2013; 8:e78099.
35. Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med 2012; 18:716-25.
36. Ulrich K, Hincks JS, Walsh R et al. Anti-inflammatory modulation of chronic airway inflammation in the murine house dust mite model. Pulm Pharmacol Ther 2008; 21:637-47.
37. Izuhara K, Ohta S, Shiraishi H et al. The mechanism of mucus production in bronchial asthma. Curr Med Chem 2009; 16:2867-75.
38. Pichery M, Mirey E, Mercier P et al. Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain. J Immunol 2012; 188:3488-95.
39. Kim HY, Chang YJ, Subramanian S et al. Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity. J Allergy Clin Immunol 2012; 129:216-27.e1-6.
40. Hardman CS, Panova V, McKenzie AN. IL-33 citrine reporter mice reveal the temporal and spatial expression of IL-33 during allergic lung inflammation. Eur J Immunol 2013; 43:488-98.
41. Li S, Aliyeva M, Daphtary N et al. Antigen-induced mast cell expansion and bronchoconstriction in a mouse model of asthma. Am J Physiol Lung Cell Mol Physiol 2014; 306:L196-206.
42. Post S, Nawijn MC, Hackett TL et al. The composition of house dust mite is critical for mucosal barrier dysfunction and allergic sensitisation. Thorax 2012; 67:488-95.
43. Williams CM, Galli SJ. The diverse potential effector and immunoregulatory roles of mast cells in allergic disease. J Allergy Clin Immunol 2000; 105:847-59.
44. Eum SY, Maghni K, Tolloczko B, Eidelman DH, Martin JG. IL-13 may mediate allergen-induced hyperresponsiveness independently of IL-5 or eotaxin by effects on airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2005; 288:L576-84.
45. Allen G, Bates JH. Dynamic mechanical consequences of deep inflation in mice depend on type and degree of lung injury. J Appl Physiol (1985) 2004; 96:293-300.